1.0Philadelphia Immunization Programhttps://vaccines.phila.govEnflonsia (Clesrovimab) Now Available Through VFC - Philadelphia Immunization Programrich600338<blockquote class="wp-embedded-content" data-secret="sPnWKjfyCp"><a href="https://vaccines.phila.gov/index.php/enflonsia-clesrovimab-now-available-through-vfc/">Enflonsia (Clesrovimab) Now Available Through VFC</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://vaccines.phila.gov/index.php/enflonsia-clesrovimab-now-available-through-vfc/embed/#?secret=sPnWKjfyCp" width="600" height="338" title="“Enflonsia (Clesrovimab) Now Available Through VFC” — Philadelphia Immunization Program" data-secret="sPnWKjfyCp" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://vaccines.phila.gov/wp-includes/js/wp-embed.min.js
</script>
On June 9, 2025, the Food and Drug Administration (FDA) licensed Merck’s Enflonsia (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI). On June 26, 2025, the Advisory Committee on Immunization Practices(ACIP) voted to recommend clesrovimab for use in infants younger...https://vaccines.phila.gov/wp-content/uploads/2025/09/Screenshot-2025-09-25-at-10.14.40-AM.png1340432